Immunotherapy for colorectal cancer: where are we heading?
D Basile, SK Garattini, M Bonotto… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: In the last few years, significant advances in molecular biology have provided
new therapeutic options for colorectal cancer (CRC). The development of new drugs that …
new therapeutic options for colorectal cancer (CRC). The development of new drugs that …
[HTML][HTML] Immunotherapy in human colorectal cancer: challenges and prospective
X Sun, J Suo, J Yan - World Journal of Gastroenterology, 2016 - ncbi.nlm.nih.gov
Human colorectal cancer (CRC) is the third most commonly diagnosed malignancies and
the prognosis for patients with recurrent or metastatic disease is extremely poor. Although …
the prognosis for patients with recurrent or metastatic disease is extremely poor. Although …
[HTML][HTML] Immunotherapy in colorectal cancer: current achievements and future perspective
A Fan, B Wang, X Wang, Y Nie, D Fan… - International Journal of …, 2021 - ncbi.nlm.nih.gov
Following dramatic success in many types of advanced solid tumors, interest in
immunotherapy for the treatment of colorectal cancer (CRC) is increasingly growing. Given …
immunotherapy for the treatment of colorectal cancer (CRC) is increasingly growing. Given …
Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress
There are increasing incidences and mortality rates for colorectal cancer in the world. It is
common for chemotherapy and radiation given to patients with colorectal cancer to cause …
common for chemotherapy and radiation given to patients with colorectal cancer to cause …
The potential role of immunotherapy to treat colorectal cancer
M Amin, AC Lockhart - Expert opinion on investigational drugs, 2015 - Taylor & Francis
Introduction: Colorectal cancer (CRC) is the fourth most common cancer and the second
leading cause of cancer-related death worldwide. Surgery, chemotherapy, radiation therapy …
leading cause of cancer-related death worldwide. Surgery, chemotherapy, radiation therapy …
[HTML][HTML] Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?
JE Olguin, MG Mendoza-Rodriguez… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is among the most prevalent and deadly neoplasms worldwide.
According to GLOBOCAN predictions, its incidence will increase from 1.15 million CRC …
According to GLOBOCAN predictions, its incidence will increase from 1.15 million CRC …
Checkpoints and beyond–immunotherapy in colorectal cancer
T Gutting, E Burgermeister, N Härtel… - Seminars in Cancer …, 2019 - Elsevier
Immunotherapy is the latest revolution in cancer therapy. It continues to show impressive
results in malignancies like melanoma and others. At least so far, effects are modest in …
results in malignancies like melanoma and others. At least so far, effects are modest in …
Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment
X He, H Lan, K Jin, F Liu - Frontiers in Immunology, 2023 - frontiersin.org
As one of the main threats to human life (the fourth most dangerous and prevalent cancer),
colorectal cancer affects many people yearly, decreases patients' quality of life, and causes …
colorectal cancer affects many people yearly, decreases patients' quality of life, and causes …
[HTML][HTML] The emerging role of immunotherapy in colorectal cancer
D Lynch, A Murphy - Annals of translational medicine, 2016 - ncbi.nlm.nih.gov
Modulation of the interaction between the immune system and the tumor microenvironment
has long been a target of cancer research, including colorectal cancer (CRC). Approaches …
has long been a target of cancer research, including colorectal cancer (CRC). Approaches …
Revolutionizing the landscape of colorectal cancer treatment: the potential role of immune checkpoint inhibitors
MF Tolba - International journal of cancer, 2020 - Wiley Online Library
Colorectal cancer (CRC) represents the third cause of cancer‐related mortalities worldwide.
The progression of CRC to the metastatic phase significantly compromises the overall …
The progression of CRC to the metastatic phase significantly compromises the overall …